Abstract:
PURPOSE: A composition containing dried powder or its fraction of sand lance fraction is provided to suppress inflammation in an animal model insuding serotonin, carrageenin, and FCA(freund's complete adjuvant). CONSTITUTION: A pharmaceutical composition for preventing and treating inflammation contains dried powder or its fraction of sand lance fraction as an active ingredient. The sand lance is from near East sea, Japan, Sakhalin island, and Okhotsk Sea or Pacific and Atlantic. The pharmaceutical composition is used in the form of powder, granule, tablet, capsule, suspension, syrup, suppository, or sterilization injection solution.
Abstract:
PURPOSE: A composition containing dried powder or extract of sand lance fraction is provided to suppress inflammation in animal model and ensure high suppression effect for arthritis in CRP(C-reactive protein) test. CONSTITUTION: A pharmaceutical composition for preventing and treating arthritis contains dried powder or its extract of sand lance fraction as an active ingredient. A method for producing the dried powder of sand lance fraction comprises: a step of washing sand lance to remove foreign materials and salt; a step of cutting the sand lance to skin, intestines, eggs, head, fin, fish bone, cartilage, muscle, eye and gill; and a step of drying through freezing and under the sun.
Abstract:
Powder of tangerine peel or an extract thereof is provided to show inhibitory effect on gastrointestinal ulcer, thereby being used as a pharmaceutical composition and a health functional food for preventing and treating gastrointestinal diseases. A pharmaceutical composition for preventing and treating gastrointestinal diseases comprises 0.1-50 wt.% of powder of tangerine peel or an extract thereof as an effective ingredient, wherein the extract is obtained by using a solvent such as water, C1-4 lower alcohol or a mixture solvent thereof. A health functional food for preventing and improving the gastrointestinal diseases comprises the powder of tangerine peel or the extract thereof as an effective ingredient. The health functional food is in a form of a granule, a tablet, a capsule, a syrup or a drink.
Abstract:
PURPOSE: A composition containing Chioneceter japonicur is provided to reduce lipid content in liver tissue and feces and to enhance SOD activity in serum. CONSTITUTION: A pharmaceutical composition for preventing and treating obesity or hypelipidemia, artheriosclerotic vascular diseases. The Chioneceter japonicur is isolated in the form of dry powder, polar solvent soluble extract, or polar solvent insoluble extract. The Chioneceter japonicur dry powder is prepared by light drying and naturally drying. A health food for preventing and treating obesity or hyperlipidemia and arteriosclerosis contains Chioneceter japonicur. The health food is powder, granules, tablets, capsules, or beverage.
Abstract:
본 발명은 오징어 분획 건조분말 또는 추출물을 유효성분으로 함유하는 고지혈증의 예방 및 치료용 조성물에 관한 것으로, 상세하게는 본 발명의 오징어 분획 건조분말 또는 추출물은 고지혈증 동물모델의 혈중 중성지질함량을 유의적으로 감소시킴으로써 항고지혈증 효과를 나타내므로, 상기 조성물은 고지혈증의 예방 및 치료용 약학조성물 또는 건강기능식품으로 유용하게 이용할 수 있다. 오징어, 혈중 중성지질, 콜레스테롤, 고지혈증, 폴록사머-407
Abstract:
PURPOSE: A composition containing cuttlefish fraction dry powder or extract is provided to reduce neutral fat in blood of animal model having hyperlipidemia and to prevent and treat hyperlipidemia. CONSTITUTION: A pharmaceutical composition for preventing and treating hyperlipidemia contains cuttlefish fraction dry powder or extract as an active ingredient. The cuttlefish fraction is cuttlefish whole body, meat, heat, leg, bone, skin, or eye. The cuttlefish fraction extract is isolated using water, 1-4 carton atoms, or mixture solvent thereof. A pharmaceutical composition contains 0.1-50 weight% of cuttlefish fraction dry powder or extract. A health food for preventing and treating hyperlipidemia contains the cuttlefish fraction dry powder or extract as an active ingredient. The health food is used in the form of powder, granule, tablet, capsule, or beverage.
Abstract:
PURPOSE: A composition containing salmon fraction-dried powder or extract thereof is provided to suppress total cholesterol content and to prevent and treat arteriosclerosis. CONSTITUTION: A pharmaceutical composition for preventing and treating arteriosclerosis contains 0.1-50 weight% of salmon fraction-dried powder or extract thereof as an active ingredient. The fraction is obtained by dividing salmon body, intestine, head, fin, bone, cartilage, muscle, eye or gill. A method for manufacturing the salmon fraction-dried powder comprise: a first step of washing salmon and removing salinity and foreign materials; a second step of cutting salmon to obtain fraction; and a third step of freeze-drying fraction and pulverizing.
Abstract:
PURPOSE: A composition containing salmon fraction-dried powder or extract thereof is provided to suppress the content of neutral fat in blood and to prevent and treat hyperlipidemia. CONSTITUTION: A pharmaceutical composition for preventing and treating hyperlipidemia contains 0.1-50 weight% of salmon fraction-dried powder or extract thereof as an active ingredient. The salmon fraction is divided to whole salmon body, intestine, head, bone, cartilage, gill and muscle. The daily dosage of active ingredient is 0.0001-100 mg/kg. A functional health food for preventing and treating hyperlipidemia contains the salmon fraction-dried powder or extract thereof as an active ingredient. The food is used in the form of beverage, tablet, capsule, pill or liquor.
Abstract:
PURPOSE: A composition containing pacific saury-fraction dried powder or its extract is provided to reduce total cholesterol content in blood and blood triglycerides. CONSTITUTION: A pharmaceutical composition for preventing and treating hyperlipidemia contains pacific saury-fraction dried powder or its extract as an active ingredient. A pacific saury fraction is obtained from total body of the pacific saury, head, bone, fin, skin, cartilage, eye, and gill. A functional health food for preventing and treating hyperlipidemia contains pacific saury-fraction dried powder or its extract as an active ingredient. The health food is used in the form of tablet, capsule, pill or liquid.
Abstract:
본 발명은 항산화 및 항동맥경화 활성을 갖는 다시마 분말 또는 알긴산이 제거된 이의 추출물을 유효성분으로 함유하는 조성물에 관한 것으로서, 상세하게는 본 발명의 다시마 분말 또는 이의 추출물은 고지혈증 또는 동맥경화증을 유도한 동물모델에서 간의 지질과산화 정도를 유의적으로 감소시키고, 혈장의 총 콜레스테롤, 트리글리세라이드, HDL-C의 함량을 유의적으로 감소시킴으로써, 고지방식이 섭취에 따른 산화적 스트레스 및 동맥경화와 고지혈증을 방어하는 효과가 있으므로, 이를 포함하는 조성물은 산화적 스트레스 및 콜레스테롤 증가로 인한 질환의 예방 및 치료를 위한 약학조성물 및 건강기능식품으로 유용하게 이용될 수 있다. 다시마 분말, 알긴산이 제거된 추출물, 항산화, 항동맥경화